- Report
- January 2024
- 200 Pages
Global
From €4818EUR$5,000USD£4,144GBP
- Report
- November 2023
- 140 Pages
Global
From €2408EUR$2,499USD£2,071GBP
- Report
- February 2024
- 113 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- November 2022
- 114 Pages
Global
From €4722EUR$4,900USD£4,061GBP
- Report
- July 2023
- 132 Pages
Global
From €915EUR$950USD£787GBP
The Pet Cancer Drugs market is a subset of the Animal Pharmaceuticals industry, which focuses on the development and production of drugs and treatments for animals. Pet Cancer Drugs are used to treat a variety of cancers in companion animals, such as cats and dogs. These drugs are designed to target the specific type of cancer and provide relief from symptoms. They can also be used to prevent the spread of cancer to other parts of the body.
The Pet Cancer Drugs market is highly competitive, with a number of companies offering a variety of products. Companies in this market include Zoetis, Elanco, Merck Animal Health, Bayer Animal Health, and Boehringer Ingelheim Animal Health. These companies are focused on developing innovative treatments and therapies to improve the quality of life for pets suffering from cancer. Show Less Read more
